Approach to Rising Drug Prices Means Rejecting International Price Controls

President Trump’s America First agenda guides his policy on everything from taxes to immigration. But his State of the Union address featured a nod to the international price-control scheme for pharmaceuticals that the Department of Health and Human Services is currently considering, which would put American interests second to bureaucratic price controls of foreign governments.

Read full story here